Consort 2010 statement: extension to cluster randomised trials

By M. Campbell, G. Piaggio, Diana Elbourne, Douglas G. Altman. British medical journal, 2012

2,133 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Statistics and Probability

View Paper: https://www.semanticscholar.org/paper/eac41f37dd7f2b76ed351d7615e79535e97ed798

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. David Moher
2. I. Boutron
3. Matthew J. Page
4. Larissa Shamseer
5. Patrick M. M. Bossuyt
6. J. Tetzlaff
7. C. Mulrow
8. J. McKenzie

In Statistics and Probability

1. David Moher
2. Matthew J. Page
3. Larissa Shamseer
4. I. Boutron
5. Patrick M. M. Bossuyt
6. C. Mulrow
7. J. Tetzlaff
8. J. McKenzie

Citations in the corpus

• Transparency, Reproducibility, and the Credibility of Economics Research (2018, neutral): “Among others, and possibly particularly relevant for some types of economics research, these include cluster randomized trials (Campbell, Elbourne, and Altman 2004; Campbell et al. 2012), non-pharmacological treatment interventions (Boutron et al.”
• Interventions for increasing the use of shared decision making by healthcare professionals. (2018, methodology): “Authors should report the methods and results of their trials in more detail by following reporting guidelines more strictly (Campbell 2012; Schulz 2010).”
• Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement. (2020, methodology): “However, no methodological advice for updating a reporting guideline exists, and only a few reporting guidelines have been updated (15-18).”